ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Bruce Morimoto |
| Institution: | Allon Therapeutics Inc |
| Department: | Drug Development |
| Country: | |
| Proposed Analysis: | To assess the sensitivity of cognitive and biomarker assessments and their longitudinal change in order to adequately determine sample size for future clinical trials. |
| Additional Investigators |

